321 related articles for article (PubMed ID: 9284865)
21. Recognition and treatment of panic disorder.
Lydiard RB
J Clin Psychiatry; 2007 Nov; 68(11):e26. PubMed ID: 18052552
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and treatment of agoraphobia with panic disorder.
Perugi G; Frare F; Toni C
CNS Drugs; 2007; 21(9):741-64. PubMed ID: 17696574
[TBL] [Abstract][Full Text] [Related]
23. Timing matters: change depends on the stage of treatment in cognitive behavioral therapy for panic disorder with agoraphobia.
Gloster AT; Klotsche J; Gerlach AL; Hamm A; Ströhle A; Gauggel S; Kircher T; Alpers GW; Deckert J; Wittchen HU
J Consult Clin Psychol; 2014 Feb; 82(1):141-53. PubMed ID: 24188509
[TBL] [Abstract][Full Text] [Related]
24. Combined psychotherapy plus benzodiazepines for panic disorder.
Watanabe N; Churchill R; Furukawa TA
Cochrane Database Syst Rev; 2009 Jan; (1):CD005335. PubMed ID: 19160253
[TBL] [Abstract][Full Text] [Related]
25. Virtual reality exposure therapy does not provide any additional value in agoraphobic patients: a randomized controlled trial.
Meyerbroeker K; Morina N; Kerkhof GA; Emmelkamp PM
Psychother Psychosom; 2013; 82(3):170-6. PubMed ID: 23548832
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of a specific model for cognitive-behavioral therapy among panic disorder patients with agoraphobia: a randomized clinical trial.
King AL; Valença AM; de Melo-Neto VL; Freire RC; Mezzasalma MA; Silva AC; Nardi AE
Sao Paulo Med J; 2011; 129(5):325-34. PubMed ID: 22069132
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcome of pharmacological and psychological treatment for panic disorder with agoraphobia: a 2-year naturalistic follow-up.
de Beurs E; van Balkom AJ; Van Dyck R; Lange A
Acta Psychiatr Scand; 1999 Jan; 99(1):59-67. PubMed ID: 10066008
[TBL] [Abstract][Full Text] [Related]
28. EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention-placebo control conditions.
Goldstein AJ; de Beurs E; Chambless DL; Wilson KA
J Consult Clin Psychol; 2000 Dec; 68(6):947-56. PubMed ID: 11142547
[TBL] [Abstract][Full Text] [Related]
29. A randomized clinical trial of cognitive behavioral therapy and interpersonal psychotherapy for panic disorder with agoraphobia.
Vos SP; Huibers MJ; Diels L; Arntz A
Psychol Med; 2012 Dec; 42(12):2661-72. PubMed ID: 22717019
[TBL] [Abstract][Full Text] [Related]
30. Clomipramine in the treatment of agoraphobic inpatients resistant to behavioral therapy.
Hoffart A; Due-Madsen J; Lande B; Gude T; Bille H; Torgersen S
J Clin Psychiatry; 1993 Dec; 54(12):481-7. PubMed ID: 8276739
[TBL] [Abstract][Full Text] [Related]
31. The relationship between agoraphobia symptoms and panic disorder in a non-clinical sample of adolescents.
Hayward C; Killen JD; Taylor CB
Psychol Med; 2003 May; 33(4):733-8. PubMed ID: 12785475
[TBL] [Abstract][Full Text] [Related]
32. Influence of panic-agoraphobic spectrum symptoms on treatment response in patients with recurrent major depression.
Frank E; Shear MK; Rucci P; Cyranowski JM; Endicott J; Fagiolini A; Grochocinski VJ; Houck P; Kupfer DJ; Maser JD; Cassano GB
Am J Psychiatry; 2000 Jul; 157(7):1101-7. PubMed ID: 10873918
[TBL] [Abstract][Full Text] [Related]
33. Combined antidepressants and CBT for panic disorder with agoraphobia.
Coupland NJ
J Psychiatry Neurosci; 2008 Mar; 33(2):176. PubMed ID: 18330461
[No Abstract] [Full Text] [Related]
34. Long-term benzodiazepine use is associated with smaller treatment gain in panic disorder with agoraphobia.
van Balkom AJ; de Beurs E; Koele P; Lange A; van Dyck R
J Nerv Ment Dis; 1996 Feb; 184(2):133-5. PubMed ID: 8596113
[No Abstract] [Full Text] [Related]
35. The role of self-directed in vivo exposure in combination with cognitive therapy, relaxation training, or therapist-assisted exposure in the treatment of panic disorder with agoraphobia.
Murphy MT; Michelson LK; Marchione K; Marchione N; Testa S
J Anxiety Disord; 1998; 12(2):117-38. PubMed ID: 9560175
[TBL] [Abstract][Full Text] [Related]
36. The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial.
Bandelow B; Broocks A; Pekrun G; George A; Meyer T; Pralle L; Bartmann U; Hillmer-Vogel U; Rüther E
Pharmacopsychiatry; 2000 Sep; 33(5):174-81. PubMed ID: 11071019
[TBL] [Abstract][Full Text] [Related]
37. Interpretive bias for benign sensations in panic disorder with agoraphobia.
Kamieniecki GW; Wade T; Tsourtos G
J Anxiety Disord; 1997; 11(2):141-56. PubMed ID: 9168339
[TBL] [Abstract][Full Text] [Related]
38. Cognitive-behavioral therapy for panic disorder with agoraphobia in older people: a comparison with younger patients.
Hendriks GJ; Kampman M; Keijsers GP; Hoogduin CA; Voshaar RC
Depress Anxiety; 2014 Aug; 31(8):669-77. PubMed ID: 24867666
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcome of panic disorder with agoraphobia treated by exposure.
Fava GA; Rafanelli C; Grandi S; Conti S; Ruini C; Mangelli L; Belluardo P
Psychol Med; 2001 Jul; 31(5):891-8. PubMed ID: 11459386
[TBL] [Abstract][Full Text] [Related]
40. Combined pharmacotherapy and cognitive behavior therapy in the treatment of panic disorder.
Gelder MG
J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):2S-5S. PubMed ID: 9872706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
